<?xml version="1.0" encoding="UTF-8"?>
<p>
 <xref rid="B23" ref-type="bibr">Cook et al. (2019)</xref> recently showed distinct but synergistic roles for IFN-α and β in controlling CHIKV replication and disease. While IFN-α acts in non-hematopoietic cell types, reducing replication and early dissemination of CHIKV, IFN-β has a substantial impact on pathogenesis, since it can limit neutrophil-mediated inflammation at the site of infection (
 <xref rid="B23" ref-type="bibr">Cook et al., 2019</xref>).
</p>
